Streptozotocin-induced diabetes selectively reduces antinociception mediated by μ1-opioid receptors, but not that mediated by μ2-opioid receptors
- 3 January 1994
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 165 (1-2) , 141-143
- https://doi.org/10.1016/0304-3940(94)90729-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect of diabetes on the antinociceptive effect of β-endorphinBrain Research, 1993
- Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptorsBrain Research, 1992
- Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic miceBrain Research, 1992
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992
- Naloxone-induced analgesia in diabetic miceEuropean Journal of Pharmacology, 1992
- Different μ receptor subtypes mediate spinal and supraspinal analgesia in miceEuropean Journal of Pharmacology, 1989
- Naloxonazine actions in vivoEuropean Journal of Pharmacology, 1986
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Irreversible opiate agonists and antagonists: the 14- hydroxydihydromorphinone azinesJournal of Neuroscience, 1982
- Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate ReceptorsScience, 1980